Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Rochlitz

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1996
MDR1 expression correlates with mutant p53 expression in colorectal cancer metastasesE de Kant, I Heide, C Thiede, et al.
DNA (Mary Ann Liebert, Inc.)|September 1, 1988
Use of the polymerase chain reaction technique to create base-specific ras oncogene mutationsC F Rochlitz, G K Scott, J M Dodson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Evidence for a mutual regulation of p53 and c-myc expression in human colorectal cancer metastasesC F Rochlitz, I Heide, C Thiede, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Cytotoxicity of ketoconazole in malignant cell linesC F Rochlitz, L E Damon, M B Russi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mutations in the ras protooncogenes are rare events in renal cell cancerC F Rochlitz, S Peter, G Willroth, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancerR A Popescu, A Lohri, E de Kant, et al.
Annals of Hematology|December 1, 1992
PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemiaC F Rochlitz, E de Kant, A Neubauer, et al.
Cancer|June 15, 1992
Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtypeC F Rochlitz, H Lobeck, S Peter, et al.
Oncology|January 1, 1993
Position specificity of Ki-ras oncogene mutations during the progression of colorectal carcinomaC F Rochlitz, I Heide, E de Kant, et al.
British Journal of Cancer|September 1, 1993
Molecular alterations in a patient with Turcot's syndromeC F Rochlitz, I Heide, E de Kant, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Cancer Research and Clinical Oncology|January 1, 1996
MDR1 expression correlates with mutant p53 expression in colorectal cancer metastasesE de Kant, I Heide, C Thiede, et al.
DNA (Mary Ann Liebert, Inc.)|September 1, 1988
Use of the polymerase chain reaction technique to create base-specific ras oncogene mutationsC F Rochlitz, G K Scott, J M Dodson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Evidence for a mutual regulation of p53 and c-myc expression in human colorectal cancer metastasesC F Rochlitz, I Heide, C Thiede, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Cytotoxicity of ketoconazole in malignant cell linesC F Rochlitz, L E Damon, M B Russi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mutations in the ras protooncogenes are rare events in renal cell cancerC F Rochlitz, S Peter, G Willroth, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancerR A Popescu, A Lohri, E de Kant, et al.
Annals of Hematology|December 1, 1992
PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemiaC F Rochlitz, E de Kant, A Neubauer, et al.
Cancer|June 15, 1992
Multiple drug resistance gene expression in human renal cell cancer is associated with the histologic subtypeC F Rochlitz, H Lobeck, S Peter, et al.
Oncology|January 1, 1993
Position specificity of Ki-ras oncogene mutations during the progression of colorectal carcinomaC F Rochlitz, I Heide, E de Kant, et al.
British Journal of Cancer|September 1, 1993
Molecular alterations in a patient with Turcot's syndromeC F Rochlitz, I Heide, E de Kant, et al.
Pageof 3